Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,031,196 papers from all fields of science
Search
Sign In
Create Free Account
dyspropterin
Known as:
6-pyruvoyl tetrahydropteridine
, 1,2-Propanedione, 1-(2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)-
, 6-pyruvoyl-tetrahydropterin
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pterins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency
J. Pietz
,
Uta Meyding-Lamadé
,
H. Schmidt
European Journal of Pediatrics
2009
Corpus ID: 29770613
White matter abnormalities on MRI have been observed in phenylketonuria (PKU) patients with late onset neurological symptoms as…
Expand
1986
1986
BH4-Biosynthesis: 1H-NMR Evidence for the Pyruvoyl-tetrahydropterin-synthase Catalyzed Formation of 6-Pyruvoyl-tetrahydropterin from Dihydroneopterin Triphosphate
S. Ghisla
,
S. Takikawa
,
P. Steinerstauch
,
T. Hasler
,
H. Curtius
1986
Corpus ID: 91301061
1985
1985
Dyspropterin, an intermediate formed from dihydroneopterin triphosphate in the biosynthetic pathway of tetrahydrobiopterin.
M. Masada
,
M. Akino
,
T. Sueoka
,
S. Katoh
Biochimica et Biophysica Acta
1985
Corpus ID: 30396717
1984
1984
Purification and properties of the enzymes from Drosophila melanogaster that catalyze the conversion of dihydroneopterin triphosphate to the pyrimidodiazepine precursor of the drosopterins.
G. Wiederrecht
,
G. M. Brown
Journal of Biological Chemistry
1984
Corpus ID: 21309797
The enzyme system responsible for the conversion of 2-amino-4-oxo-6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihyd roptridine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE